U.S. Office REITs Stock News

Insider selling sparks fresh questions for Vicor (VICR) Recent insider selling at Vicor (VICR), led by CEO Patrizio Vinciarelli’s 50,000 share sale, has drawn investor attention after the transactions coincided with an 8.5% one day drop in the stock. With other insiders also selling and Vicor shares showing increased volatility, many investors are reassessing what this activity might signal about management’s risk tolerance, time horizon, and use of equity-based compensation. See our latest...

Powell Industries (POWL) has drawn fresh attention after announcing a three-for-one forward stock split, paired with an increase in authorized shares. The move is designed to support liquidity and future corporate flexibility. See our latest analysis for Powell Industries. The stock split headlines come on top of a sharp move in the share price, with a 90 day share price return of 73.8% and a year to date share price return of 57.17%, while the 1 year total shareholder return is 206.77%. This...

Wondering if Lumentum Holdings at around US$764.65 is still offering value, or if the easy gains are behind it? This article is built to help you weigh that up through a clear look at what the current price actually reflects. The share price has seen a 1.6% decline over the last 7 days and a 2.4% decline over the last 30 days, yet year to date the stock is up 98.0% and the 1 year return is very large at over 10x. Recent coverage has focused on Lumentum’s role in the broader tech sector and...

Meta Platforms (NasdaqGS:META) and EssilorLuxottica have expanded their AI smart glasses lineup with new Ray-Ban Meta optical-first models designed for prescription wearers. The collection introduces AI features such as live translation in more languages, hands-free food logging, and personalized controls. The new eyewear range is set to reach additional international markets, widening access to Meta’s AI hardware portfolio. For investors watching NasdaqGS:META, this move adds another piece...

Vertex Pharmaceuticals received FDA approval to expand the use of ALYFTREK and TRIKAFTA to additional age groups and CFTR gene variants. The expanded labels make CFTR modulator treatment options available to an estimated 95% of people with cystic fibrosis in the US. These decisions materially increase the eligible US patient pool for Vertex's cystic fibrosis franchise. For investors tracking NasdaqGS:VRTX, the fresh label expansions arrive as the stock trades around $447.26. Shares have...

Recently, Everus Construction Group reported earnings and revenue that exceeded analyst forecasts, alongside a record backlog in its specialized infrastructure and commercial construction services. This combination of stronger-than-expected operating results, a growing project pipeline, and increased institutional interest has sharpened investor focus on Everus’ role in data center, transmission, and distribution build-outs. With Everus’ record backlog underscoring robust demand, we’ll now...

MSC Industrial Direct (MSM) has put fresh numbers on the board for Q2 2026, with Q1 2026 revenue at US$965.7 million and basic EPS of US$0.93, set against a trailing twelve month EPS of US$3.67 on revenue of US$3.8 billion. Over recent quarters, revenue has ranged from US$891.7 million to US$978.2 million, while quarterly basic EPS has moved between US$0.70 and just over US$1.02. This gives investors a clear view of how earnings and sales have been tracking as margins come under pressure. See...

Taylor Devices (TAYD) just turned in its Q3 2026 scorecard, with recent quarterly figures showing revenue between about US$8.5 million and US$15.6 million over the past six reported quarters and EPS ranging from US$0.34 to US$1.17. Across that stretch, revenue moved from US$8.55 million in Q2 2025 to US$11.60 million in Q2 2026, while EPS shifted from US$0.34 to US$0.64, setting up a results season in which investors are paying close attention to how firmly margins are holding. See our full...

NVR (NVR) has drawn investor attention after recent share price swings, with the stock showing a month decline of about 10% and a past 3 months decline of roughly 9%. See our latest analysis for NVR. The recent 1 day share price return of 1.13% and 7 day share price return of 1.71% sit against a weaker backdrop, with a 30 day share price return showing a decline of 10.13% and a 1 year total shareholder return showing a decline of 8.74%, suggesting momentum has been fading after earlier multi...

In late March 2026, Dow Inc. highlighted its role in addressing petrochemical supply disruptions linked to Middle East tensions, with management warning that shortages and higher input costs could raise prices across construction materials, consumer goods, automotive, and aerospace industries. While analysts still anticipate weaker near-term profitability, investors are increasingly focused on how Dow’s extensive U.S. Gulf Coast production footprint may benefit from tighter global supply and...

Amphenol (APH) is back in focus after a mix of catalysts, including anticipated fiscal 2026 first quarter earnings, a Jefferies rating upgrade and sector wide selling linked to rising geopolitical tensions. See our latest analysis for Amphenol. The current share price of US$127.70 comes after a 1 day share price return of 1.07%, following a softer 30 day share price return of 5.52% and sector wide selling linked to geopolitical tensions. However, the 1 year total shareholder return of 89.40%...

Wells Fargo’s recent upgrade of Sempra (SRE) to Overweight has put fresh attention on the utility as investors weigh what business simplification and planned transactions with KKR and Ecogas could mean for the stock. See our latest analysis for Sempra. Recent moves in Sempra’s share price suggest momentum has been building, with a 10.33% 90 day share price return and 8.58% year to date share price return, while the 1 year total shareholder return stands at 37.81%. If Wells Fargo’s upgrade has...

Recent attention on Itron (ITRI) has been driven by concerns around its slower revenue trajectory, with both its historical 1.7% annual growth and its projected 2.1% sales growth raising questions about demand and profitability. See our latest analysis for Itron. The share price has eased back recently, with a 7 day share price return of 3.34% and a 30 day share price return of 4.98%, while the 1 year total shareholder return of 15.78% contrasts with a 3 year total shareholder return of...

XCF Global (SAFX) closed FY 2025 with Q4 revenue of US$4.7 million and a basic EPS loss of US$0.09, alongside trailing twelve month EPS of US$0.52 on revenue of US$20.8 million that reflects the move into profitability over the past year. Over recent quarters the company has seen revenue shift from US$0 in Q1 2025 to US$6.6 million in Q2, US$9.6 million in Q3, then US$4.7 million in Q4. Quarterly EPS moved from a loss of US$0.05 in Q1 to a gain of US$0.83 in Q2 before returning to losses in...

Dave & Buster's Entertainment (PLAY) has just wrapped up FY 2026 with fourth quarter revenue of US$529.6 million and a basic EPS loss of US$1.15, as net income excluding extra items came in at a loss of US$39.8 million. Over the past year, quarterly revenue has moved between US$448.2 million and US$567.7 million, while basic EPS has ranged from a profit of US$0.63 in the first quarter to losses of around US$1.15 to US$1.22 in the back half of the year. This sets up a complex picture for...

Freeport-McMoRan Inc. recently declared a US$0.15 per share cash dividend on its common stock, combining a US$0.075 base payout and a US$0.075 variable component under its performance-based framework, while Board member Robert W. Dudley confirmed he will not stand for re-election at the 2026 annual meeting. This mix of a performance-linked dividend and an orderly Board transition comes as analysts project very large near-term earnings growth and maintain a strongly positive consensus view on...

Leadership change and what it could mean for Rush Enterprises stock Rush Enterprises (RUSH.A) has appointed long time executive Jody Pollard as Chief Operating Officer, replacing Jason Wilder. This shift places internal operational experience at the center of investor attention. See our latest analysis for Rush Enterprises. The leadership change comes as Rush Enterprises trades at US$66.02, with a 30 day share price return of an 8.76% decline, a 90 day share price return of 22.40% and a 5...

Why Forestar Group is on investors’ radar today Forestar Group (FOR) has drawn fresh attention after a period where the share price showed mixed short term moves, including a 1 day gain alongside weaker returns over the month. For readers tracking real estate related names, the stock’s recent share performance and financial profile, including revenue of US$1,685.0 million and net income of US$166.8 million, raise questions about how the market is currently viewing its valuation. See our...

Lamb Weston Holdings (LW) has put fresh numbers on the board for Q3 2026, with quarterly revenue of about US$1.6b and basic EPS of US$0.45, while the latest trailing twelve month figures show revenue of roughly US$6.5b and EPS of US$2.80. Over recent periods the company has seen quarterly revenue move between about US$1.52b and US$1.68b and basic EPS range from a loss of US$0.25 per share to US$1.03 per share, alongside trailing twelve month EPS running between roughly US$2.08 and US$2.80...

In recent weeks, Goldman Sachs Group has issued a broad range of new fixed-income securities across currencies and maturities while benefiting from Basel III revisions that reduce capital requirements for large banks, supporting its capacity to lend, underwrite and return capital. Analysts now see a stronger business outlook driven by expectations for increased mergers and acquisitions activity and deeper use of artificial intelligence across Goldman’s operations, which together could...

If you are wondering whether Republic Bancorp's current share price gives you good value, the starting point is understanding how that price lines up against a few different valuation yardsticks. The stock last closed at US$70.96, with returns of 3.2% over 7 days, 1.7% over 30 days, 4.3% year to date, 13.4% over 1 year, 89.0% over 3 years and 82.2% over 5 years, which gives useful context before comparing the price to value. Recent attention on Republic Bancorp has centered on its role in...

For readers wondering whether Illumina at around US$126.63 is priced for opportunity or already reflects the current story, this article walks through what the share price might be implying about value. The stock has had a mixed run, with a 0.3% return over 7 days and a 4.7% decline over 30 days, set against a 54.7% gain over the past year and longer term declines of 43.6% over 3 years and 67.5% over 5 years. These moves have come as Illumina remains in focus for investors, following ongoing...

Insulet (PODD) recently disclosed a voluntary device correction for certain Omnipod 5 lots after 18 serious adverse events, including hospitalizations and diabetic ketoacidosis, while affirming its existing outlook and excluding remediation costs from non GAAP results. See our latest analysis for Insulet. The voluntary device correction and recent executive appointments come at a time of softer share performance, with a 30 day share price return of 15.65% and a 1 year total shareholder return...

Royal Caribbean Group and Bank of America recently launched the Royal ONE and Royal ONE Plus tri-branded Visa Signature credit cards, allowing guests to earn and redeem rewards across Royal Caribbean, Celebrity Cruises, and Silversea with tiered point multipliers and travel perks. The new cards deepen Royal Caribbean Group’s loyalty ecosystem by tying everyday spending to cruise savings and onboard credits, reinforcing its focus on higher-value, repeat guests. Next, we’ll explore how this...